scanX
Home
Syschem

Syschem

43.20
+0.13
(0.30%)
Market Cap (₹ Cr.)
₹172
52 Week High
73.90
Book Value
₹
52 Week Low
39.45
PE Ratio
138.94
PB Ratio
3.01
PE for Sector
38.61
PB for Sector
4.60
ROE
4.85 %
ROCE
6.49 %
Dividend Yield
0.00 %
EPS
₹0.31
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
78.87 %
Net Income Growth
-38.81 %
Cash Flow Change
-202.12 %
ROE
-76.04 %
ROCE
-36.11 %
EBITDA Margin (Avg.)
-55.04 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
7
3
0
0
0
0
0
0
12
9
9
15
33
29
28
10
26
16
25
15
20
11
17
19
22
17
11
10
20
15
20
30
49
43
37
44
75
88
Expenses
8
3
0
0
1
0
0
1
11
9
9
14
31
27
27
10
25
16
24
16
20
11
18
20
26
18
12
11
17
14
18
27
46
41
35
43
73
87
EBITDA
-1
-0
-0
-0
-1
-0
-0
-1
1
0
0
1
2
1
1
1
1
1
1
-1
-0
0
-0
-1
-4
-1
-1
-0
3
1
2
3
3
2
2
1
2
1
Operating Profit %
-18 %
-7 %
-117 %
-3 %
-138 %
0 %
-3 %
-500 %
5 %
0 %
-1 %
3 %
4 %
4 %
3 %
5 %
3 %
3 %
1 %
-7 %
-3 %
1 %
-2 %
-5 %
-18 %
-5 %
-10 %
-4 %
14 %
9 %
10 %
10 %
5 %
6 %
5 %
2 %
2 %
1 %
Depreciation
0
0
0
0
1
1
1
1
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Interest
-2
0
-0
2
-2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0
0
0
0
0
0
Profit Before Tax
1
-1
-1
-3
1
-1
-1
-1
0
-0
-0
0
1
1
1
0
0
0
0
-2
-1
-0
-1
-2
-4
-1
-2
-1
2
1
1
2
2
2
1
0
1
0
Tax
0
0
0
0
-1
0
0
0
-1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
2
-1
-1
-3
2
-1
-1
-1
1
-0
-0
0
1
1
1
0
-0
0
0
-2
-1
-0
-1
-2
-3
-1
-2
-1
2
1
1
2
0
2
1
0
-0
0
EPS in ₹
1.24
-0.48
-0.03
-1.66
1.06
-0.03
-0.35
-0.72
0.05
-0.24
-0.21
0.10
0.72
0.36
0.31
0.03
-0.24
0.06
0.08
-0.84
-0.29
-0.20
-0.47
-0.72
-1.22
-0.69
-0.74
-0.43
1.07
0.28
0.48
0.67
0.12
0.53
0.35
0.06
-0.07
0.03
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
51
47
44
58
62
62
77
60
93
164
Fixed Assets
34
32
29
29
27
28
30
32
31
31
Current Assets
15
13
11
26
32
31
42
24
59
126
Capital Work in Progress
1
1
1
0
0
1
1
0
0
4
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
16
15
14
28
35
34
46
28
62
129
Total Liabilities
40
38
37
49
50
52
70
53
70
107
Current Liabilities
19
18
22
34
37
39
41
26
43
97
Non Current Liabilities
21
20
15
14
13
14
29
27
27
10
Total Equity
11
9
7
9
12
10
7
7
22
57
Reserve & Surplus
-6
-8
-9
-7
-7
-9
-14
-16
-10
17
Share Capital
17
17
16
16
19
19
22
23
32
40
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
0
-0
0
0
-0
-0
0
1
-0
Investing Activities
0
0
0
0
2
-4
-4
-1
-2
-6
Operating Activities
1
0
6
0
-2
3
4
1
-8
-26
Financing Activities
-2
-1
-7
-0
-0
-0
-0
-0
11
32
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Nov 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
9.54 %
9.54 %
16.34 %
16.34 %
16.34 %
21.78 %
52.10 %
53.82 %
53.82 %
53.82 %
53.79 %
56.29 %
53.89 %
53.89 %
53.89 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.14 %
0.25 %
0.25 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
90.46 %
90.46 %
83.66 %
83.66 %
83.66 %
78.22 %
47.90 %
46.18 %
46.18 %
46.18 %
46.21 %
43.71 %
45.97 %
45.86 %
45.86 %

Dividend History

No dividends have been distributed by the company in the past 10 years

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,910.05 4,59,136.75 43.54 49,887.17 12.06 9,648 42.62 65.70
Cipla
1,623.30 1,33,733.09 30.09 26,520.66 14.17 4,155 17.77 47.50
Dr Reddys Laboratories
6,633.25 1,12,386.62 20.19 28,905.40 12.36 5,578 -0.90 43.03
Zydus Life Science
1,057.35 1,07,551.32 25.80 19,831.50 13.82 3,831 30.78 36.39
Mankind Pharma
2,611.65 1,01,378.99 51.66 10,615.63 19.57 1,942 9.89 58.64
Lupin
2,198.25 99,598.89 44.00 20,141.50 19.94 1,936 77.69 52.72
Aurobindo Pharma
1,466.05 85,418.13 23.81 29,559.25 17.55 3,169 61.17 42.40
Alkem Laboratories
6,194.15 73,643.07 34.26 12,978.42 9.84 1,811 91.18 56.20
Glenmark Pharmaceuticals
1,662.70 46,424.18 - 12,653.09 6.58 -1,831 96.52 49.66
Biocon
346.35 42,855.42 27.46 15,621.20 35.25 1,298 478.78 38.92

Corporate Action

Technical Indicators

RSI(14)
Neutral
35.62
ATR(14)
Less Volatile
2.04
STOCH(9,6)
Neutral
22.56
STOCH RSI(14)
Neutral
21.04
MACD(12,26)
Bearish
-0.35
ADX(14)
Strong Trend
33.76
UO(9)
Bearish
35.93
ROC(12)
Downtrend But Slowing Down
-7.59
WillR(14)
Neutral
-78.58
Bearish
5
Neutral
3
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Technical Screeners
Candlestick Screeners
Intraday Screeners
Fundamental Screeners
Price & Volume Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.